Next Generation Healthcare Technology

Next Generation Healthcare Technology Mobile Apps - der neue Weg zum Kunden/Patienten? Alexander Frenzel Engagement Manager 28. April 2016 1 Agend...
Author: Stephen Long
2 downloads 1 Views 2MB Size
Next Generation Healthcare Technology

Mobile Apps - der neue Weg zum Kunden/Patienten?

Alexander Frenzel Engagement Manager 28. April 2016 1

Agenda Vorträge digital health - wie mobile Technologien den Arztbesuch der Zukunft prägen Dr. med. Johannes Jacubeit, CEO, connected-health.eu GmbH Smart digital therapies durch Machine Learning - wie Apps als Medizinprodukt das Gesundheitswesen verändern André Sommer, Co-Founder, HiDoc GbR Praxisbericht: Im Smartphone des Patienten mit Care4Today - Kein Kochrezept, aber Zutaten & Tipps damit es allen schmeckt Tanja Neumann, Digital Marketing Manager Infektiologie & Immunologie, Janssen-Cilag GmbH

3

© 2016, IMS HEALTH – Next Generation Healthcare Technology

The mHealth field is wide and expanding 2/3 mHealth apps are focused on wellness

Wellness Management

mHealth apps continue to proliferate at pace

Fitness

2%

90,088

Lifestyle & Stress

11%

Diet & Nutrition

6%

46.399

36%

7%

43,689

9% 12%

106%

17% Disease & Treatment Management Healthcare Providers / Insurance

2013

Medication Reminders & Info Women’s Health & Pregnancy Disease Specific mHealth Apps by Category, 2015

Other

Comparison of iOS mhealth Apps 2013 and 2015

Source: Mevvy, June 2015; IMS Health AppScript, June 2015; IMS Institute for Healthcare Informatics, August 2015 4

© 2016, IMS HEALTH – Next Generation Healthcare Technology

2015

mHealth market trends Empowered patients, but unclear market settings and regulations • Digital health apps empower patients through improving health & disease education • Self management is improved • Self efficacy of patient is improved to drive behavioral change • Changing interactions of HCPs and patients

patients

• Health app are developed outside the “classic“ healthcare system • Market offerings are “supply-side“ driven, low costs in development leave thousands of unused health apps in the stores • Immature “classic” stakeholder engagements in the digital realm, e.g. payers

Immature mHealth market

• The mHealth market is obscure, no adequate evaluation process for innovations • Med tech legislation applies, but not enforced: 50% Single Function

Fill Rate

20%

40%

60%

80%

Pharma finding a position in the mHealth market Three imperatives – to be discussed

10

Develop patient centric services

• Content and value for the user determines use in a very competitive environment

Develop mHealth technology capabilities

• Technology capabilities internalized, even for partnering

Evolve the mHealth regulatory setting

• Regulatory bodies will be late to shape the market

• From brand to patient centric communication & servicing

• Service development only possible with technologist perspective

• Self-regulation needed due to specific capabilities needed for the evaluations, e.g. App Check, IMS AppScript

© 2016, IMS HEALTH – Next Generation Healthcare Technology

IMS AppNucleus™ Secure Patient Engagement IMS AppNucleusTM has five key components that can be rapidly customized for mHealth solutions

11

Presenting three mHealth apps in our session From health information to therapy support to clinic organization 1. digital health - wie mobile Technologien den Arztbesuch der Zukunft prägen Johannes Jacubeit, connected-health.eu 2. Smart digital therapies durch Machine Learning - wie Apps als Medizinprodukt das Gesundheitswesen verändern André Sommer, HiDoc 3. Praxisbericht: Im Smartphone des Patienten mit Care4Today - Kein Kochrezept, aber Zutaten & Tipps damit es allen schmeckt Tanja Neumann, Janssen

12

© 2016, IMS HEALTH – Next Generation Healthcare Technology

13

© 2016, IMS HEALTH – Next Generation Healthcare Technology

© 2016, IMS HEALTH GmbH & Co. OHG All rights reserved. The information may not be duplicated, stored, further processed, nor be made accessible in whole or in part to any third party without the prior express written consent of IMS HEALTH. In connection with data/figures used terms, such as „patient, doctor, medical practice, prescriber or pharmacy”, do not designate any personal data but exclusively anonymous information (in accordance with § 3 Abs. 6 “Bundesdatenschutzgesetz” – German Federal Data Protection Act) IMS employs high sophisticated technologies and methods which ensure all its Information Services to meet the applicable data-protection requirements, regardless the way data are combined with one another.

14

© 2016, IMS HEALTH – Next Generation Healthcare Technology

Suggest Documents